CNCR vs. PSIL

Last updated Jun 4, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and PSIL (AdvisorShares Psychedelics ETF) are both Health & Biotech Equities funds. CNCR is passively managed, while PSIL is actively managed. CNCR charges 0.79%/yr vs 1.00%/yr for PSIL.

Performance

CNCR vs. PSIL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and AdvisorShares Psychedelics ETF (PSIL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

PSIL

• 1D: -3.49%
• 1M: 5.19%
• YTD: 23.33%
• 6M: 29.24%
• 1Y: 72.93%
• 3Y*: 10.51%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. PSIL - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
PSIL AdvisorShares Psychedelics ETF	28.26%

CNCR vs. PSIL - Sectors Allocation Comparison

Sectors	CNCR	PSIL
Healthcare	96.6%	100.0%
Financial Services	3.3%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CNCR vs. PSIL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSIL

PSIL Risk / Return Rank: 52
PSIL Sharpe Ratio Rank: 50
PSIL Sortino Ratio Rank: 45
PSIL Omega Ratio Rank: 45
PSIL Calmar Ratio Rank: 74
PSIL Martin Ratio Rank: 47

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. PSIL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and AdvisorShares Psychedelics ETF (PSIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CNCR	PSIL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.76	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.41	—

Drawdowns

CNCR vs. PSIL - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum PSIL drawdown of -92.72%. Use the drawdown chart below to compare losses from any high point for CNCR and PSIL.

Drawdown Indicators

	CNCR	PSIL	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-92.72%	+92.72%
Max Drawdown (1Y) Largest decline over 1 year	—	-20.38%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-64.62%	—
Current Drawdown Current decline from peak	0.00%	-76.01%	+76.01%
Average Drawdown Average peak-to-trough decline	0.00%	-76.76%	+76.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	9.62%	—

Volatility

Volatility by Period

	CNCR	PSIL	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	9.35%	—
Volatility (6M) Calculated over the trailing 6-month period	—	28.02%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	41.78%	-41.78%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	63.17%	-63.17%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	63.17%	-63.17%

CNCR vs. PSIL - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is lower than PSIL's 1.00% expense ratio.

Dividends

CNCR vs. PSIL - Dividend Comparison

CNCR has not paid dividends to shareholders, while PSIL's dividend yield for the trailing twelve months is around 8.10%.

Position	TTM	2025	2024	2023	2022
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%
PSIL AdvisorShares Psychedelics ETF	8.10%	10.95%	1.49%	0.24%	2.91%

Frequently Asked Questions

Which ETF is better, CNCR or PSIL?

On fees, CNCR is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or PSIL?

CNCR is cheaper with a 0.79% expense ratio, compared with 1.00% for PSIL.

Which ETF pays a higher dividend yield, CNCR or PSIL?

PSIL has the higher dividend yield at 8.10%, compared with 0.00% for CNCR.

What is the main difference between CNCR and PSIL?

They also come from different issuers: Exchange Traded Concepts and AdvisorShares. Their fees differ too: 0.79% for CNCR and 1.00% for PSIL.